Trial intelligence / Profile preview

Deferiprone and Deferasirox Combination in Beta-Thalassemia

NCT02198508Completed

Sponsor
China Medical University Hospital
Start
Jul 2007
Primary completion
Jul 2008
Modality
Small Molecules
01

Overview

Randomised, open-label trial of deferiprone and deferasirox in beta thalassemia, sponsored by China Medical University Hospital. Started Jul 2007; status: completed.

02

Drugs

deferipronedeferasirox
03

Conditions

beta thalassemia

Beyond the preview

Go deeper on NCT02198508.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02198508.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call